Steroidal glycoside cholesterol absorption inhibitors

Journal of Medicinal Chemistry

Volumn 40, Issue 16, 1997, Pages 2547-2554

  DeNinno, Michael P ^a   McCarthy, Peter A ^a   Duplantier, Kimberly C ^a   Eller, Cynthia ^a   Etienne, John B ^a   Zawistoski, Michael P ^a   Bangerter, Faan Wen ^a   Chandler, Charles E ^a   Morehouse, Lee A ^a   Sugarman, Eliot D ^a   Wilkins, Robert W ^a   Woody, Heidi A ^a   Zaccaro, Lawrence M ^a  

^a PFIZER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

11 KETOTIGOGENIN; CELLOBIOSE; CHOLESTEROL; GLYCOSIDE; PAMAQUESIDE; STEROID; TIQUESIDE; UNCLASSIFIED DRUG;

ARTICLE; BINDING AFFINITY; CHOLESTEROL METABOLISM; DOSE RESPONSE; DRUG DETERMINATION; DRUG POTENCY; HAMSTER; PROTEIN BINDING; STEROID BINDING; STEROIDOGENESIS;

ABSORPTION; ANIMALS; ANTILIPEMIC AGENTS; CHOLESTEROL; CRICETINAE; DRUG DESIGN; LIVER; MODELS, CHEMICAL; SAPONINS; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 15444346097     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm9702600     Document Type: Article

References (25)

1. (a) Sliskovic, D. R.; Trivedi, B. K. ACAT Inhibitors: potential antiatherosclerotic agents. Curr. Med. Chem. 1994, 1, 204-225.
2. (b) Matsuda, K. ACAT Inhibitors as antiatherosclerotic agents: compounds and mechanisms. Med. Res. Rev. 1994, 14, 271-305.
3. (a) Lopenzcandales, A.; Bosner, M. S.; Spilburg, C. A.; Lange, L. G. Cholesterol transport function of pancreactic cholesterol esterase: directed sterol uptake and esterifiction in enterocytes. Biochemistry 1993, 32, 12085-12089.
4. 14C]-cholesterol absorption in animal models. FASEB J. 1992, 6, A1388.
5. (c) Gallo, L. L. Sterol ester hydrolase from rat pancreas. Methods Enzymol. 1981, 71, 664-674.
6. (a) Salisbury, B. G.; Davis, H. R.; Burrier, R. E.; Burnett, D. A.; Boykow, G.; Caplen, M. A.; Clemmons, A. L.; Compton, D. S.; Hoos, L. M.; McGregor, D. G.; Schnitzer-Polokoff, R.; Smith, A. A.; Weig, B. C.; Zilli, D. L.; Clader, J. W.; Skybertz, E. J. Hypocholesterolemic activity of a novel inhibitor of cholesterol absorption, SCH 48461. Atherosclerosis 1995, 115, 45-63.
7. (b) Burnett, D. A.; Caplen, M. A.; Davis, H. R., Jr.; Burrier, R. E.; Clader, J. W. 2-Azetidinones as inhibitors of cholesterol absorption. J. Med. Chem. 1994, 37, 1733-1736.
8. Himber, J.; Missano, B.; Rudling, M.; Hennes, U.; Kempen, H. J. Effects of stigmastanyl-phosphocholine (Ro 16-6532) and lovastatin on lipid and lipoprotein levels and lipoprotein metabolism in the hamster on different diets. J. Lipid Res. 1995, 36, 1567-1585.
9. Dressman, J. B.; Adair, C. H.; Barnett, J. L.; Berardi, R. R.; Dunn-Kucharski, V. A.; Jarvenpaa, K. M.; Parr, D. D.; Sowle, C. A.; Swidan, S. Z.; Tobey, S. W.; Reppas, C. High molecular-weight hydroxypropylmethylcellulose. Arch. Intern. Med. 1993, 153, 1345-1353.
10. (a) Malinow, M. R. Effects of synthetic glycosides on cholesterol absorption. Ann. N. Y. Acad. Sci. 1985, 454, 23-27.
11. (b) Sidhu, G. S.; Upson, B.; Malinow, M. R. Effect of soy saponins and tigogenin cellobioside on intestinal uptake of cholesterol, cholate and glucose. Nutr. Rep. Internal. 1987, 35, 615-623.
12. (c) Malinow, M. R.; Elliott, W. H.; McLaughlin, P.; Upson, B. Effects of synthetic glycosides on steroid balance in Macaco fascicularis. J. Lipid Res. 1987, 28, 1-9.
13. (d) Harwood, H. J., Jr.; Chandler, C. E.; Pellarin, L. D.; Bangerter, F. W.; Wilkins, R. W.; Long, C. A.; Cosgrove, P. C.; Malinow, M. R.; Marzetta, C. A.; Pettini, J. L.; Savoy, Y. E.; Mayne, J. T. Pharmacologic consequences of cholesterol absorption inhibition: alteration in cholesterol metabolism and reduction in plasma cholesterol concentration induced by the synthetic saponin β-tigogenin cellobioside (CP-88,818; tiqueside). J. Lipid Res. 1993, 34, 377-395.
14. Dujovne, C. A.; Harris, W. S.; Gelfand, R. A.; Morehouse, L. A.; McCarthy, P. A.; Chandler, C. A.; DeNinno, M. P.; Harwood, H. J., Jr.; Newton, F. A.; Shear, C. L. Investigations of the effects of synthetic saponins on cholesterol absorption and serum cholesterol levels. In Atherosclerosis X; Woodford, F. P., Davignon, J., Sniderman, A., Eds.; Elsevier Science: New York, 1995; pp 298-306.
15. Turley, S. D.; Spady, D. K.; Dietschy, J. M. Regulation of fecal bile acid excretion in male golden Syrian hamsters fed a cereal-based diet with and without added cholesterol. Hepatology 1997, 25, 797-803 and references cited therein.
16. Kelly, J. J.; Tsai, A. C. Effect of pectin, gum arabic and agar on cholesterol absorption, synthesis and turnover in rats. J. Nutr. 1978, 108, 630-639.
17. 50 values. See the Experimental Section for complete details.
18. Walinsky, S. W.; Lambert, J. F.; Goggin, K. D. Zinc fluoride-activated glycoside syntheses. Tigogenyl β-O-cellobioside as a novel cholesterol lowering agent. Abstracts from the 208th ACS National Meeting, Washington, DC, August 1994; CARB 11.
19. Toshima, K.; Tatsuta, K. Recent progress in O-glycosidation methods and its application to natural products synthesis. Chem Rev. 1993, 93, 1503-1531.
20. Duggan, M. E.; Imagire, J. S. Copper(I) chloride catalyzed addition of alcohols to alkyl isocyanates. A mild and expedient method for alkyl carbamate formation. Synthesis 1989, 131-132.
21. McCarthy, P. A.; DeNinno, M. P.; Morehouse, L. A.; Chandler, C. E.; Bangerter, F. W.; Wilson, T. C.; Urban, F. J.; Walinsky, S. W.; Cosgrove, P. G.; Duplantier, K. C.; Etienne, J. B.; Fowler, M. A.; Lambert, J. F.; O'Donnell, J. P.; Pezzullo, S. L.; Watson, H. A., Jr.; Wilkins, R. W.; Zaccaro, L. M.; Zawistoski, M. P. 11-Ketotigogenin cellobioside (pamaqueside): a potent cholesterol absorption inhibitor in the hamster. J. Med. Chem. 1996, 39, 1935-1937.
22. (a) Grundy, S. M.; Mok, H. Y. I. In Lipoprotein Metabolism; Greten, H., Ed.; Springer-Verlag: New York, 1976; pp 112-118.
23. (b) Lees, R. S.; Lees, A. M. In Lipoprotein Metabolism; Greten, H., Ed.; Springer-Verlag: New York, 1976; pp 119-124.
24. (c) Oster, P.; et. al. In Lipoprotein Metabolism; Greten, H., Ed.; Springer-Verlag: New York, 1976; pp 125-130.
25. Chandler, C. E.; Morehouse, L. A. Unpublished results.